ALAYA.BIO
Live / Applied — Final refusal mailed (as of 11 Mar 2026)
What this means for you
Not registered yet, but its 26 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79408189
- Mark type
- Stylized text
- Filed
- 26 Jul 2024
- Attorney of record
- Boris Umansky
Goods and services
- Class 005 — Pharmaceuticals: Biotechnology-derived products and preparations applied to the medical field, namely, gene and cell therapy products and preparations for medical purposes; gene and cell therapy products and preparations, namely, cells targeting polymeric nanoparticle based on vector payloads for medical purposes; medical products, substances and preparations, namely, biotechnology-derived products and preparations being cell targeting preparations and products in the nature of polymeric nanoparticle based on vector payloads and pharmaceutical products for immunotherapy and cancer treatment, autoimmune diseases, genetic diseases, diseases affecting the central nervous system; none of the aforementioned goods relating to or being in the nature of nutritional supplements
- Class 042 — Scientific and technological services: Medical research; pharmacological research being pharmaceutical research services; research and development in the field of biotechnology; biotechnology advice, namely, consulting services in the field of biotechnology and cell and gene therapy; preparation of reports in the field of biotechnology for scientific research purposes; information about scientific research in the field of biochemistry and biotechnology; scientific research in the fields of cell therapy and gene therapy; scientific research in the fields of in-vivo gene therapy and cell therapy; medical and scientific research in the field of immunotherapy; medical and scientific research in the field of oncology; medical and scientific research in the field of autoimmune disease; medical and scientific research in the field of genetic disease; medical and scientific research in the field of diseases affecting the central nervous system
Owner
- Alaya.bio, FR
Prosecution history
- 16 Apr 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 30 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 29 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 11 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 11 Mar 2026 — FINAL REFUSAL E-MAILED
- 11 Mar 2026 — FINAL REFUSAL WRITTEN
- 30 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Apr 2025 — REFUSAL PROCESSED BY IB
- 31 Mar 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 31 Mar 2025 — REFUSAL PROCESSED BY MPU
- 26 Feb 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 25 Feb 2025 — NON-FINAL ACTION WRITTEN
- 03 Feb 2025 — ASSIGNED TO EXAMINER